We studied phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6P) mRNA expression in the liver because an increase in the expression of these genes is associated with hepatic insulin resistance. The gene discussed is PCK2; the disease is Insulin resistance.